Home > Boards > US Listed > Biotechs >

Soligenix, Inc. (SNGX)

SNGX RSS Feed
Add SNGX Price Alert      Hide Sticky   Hide Intro
Moderator: TruckingAngler
Search This Board: 
Last Post: 5/19/2022 3:33:28 PM - Followers: 206 - Board type: Free - Posts Today: 0

Soligenix as of 9/09/2021: 
SNGX [NASD]
Soligenix, Inc.
Healthcare | Biotechnology | USA
https://finviz.com/quote.ashx?t=SNGX&ty=c&ta=1&p=d

[-chart]www.soligenix.com/wp-content/uploads/2019/05/T-cells.png[/chart]



[-chart]finviz.com/chart.ashx?t=SONN&ty=c&ta=1&p=d&s=l[/chart]
 

https://www.soligenix.com/
https://www.soligenix.com/about/
https://www.soligenix.com/pipeline-programs/
https://www.soligenix.com/clinical-trials/
https://www.soligenix.com/our-focus/
https://www.soligenix.com/partnering/
 

Soligenix, Inc. (Soligenix) is a late-stage biopharmaceutical company.
The Company is focused on developing and commercializing products to treat rare diseases.
The Company operates through two business segments:
Specialized BioTherapeutics and Public Health Solution. Soligenix’s Specialized BioTherapeutics business segment is developing
a photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma (CTCL).
The Public Health Solutions business segment includes active development programs for RiVax,
its ricin toxin vaccine candidate and SGX943, its therapeutic candidate for antibiotic-resistant and emerging infectious disease.
CTCL is its innate defense regulator technology, dusquetide (SGX942) for the treatment of oral mucositis in head and neck cancer.

 
 

Specialized BioTherapeutics Pipeline

Soligenix has expertise in the development of orphan and unmet medical need indications including preclinical, manufacturing, regulatory and clinical expertise.

 

 

Rising to the challenges of rare disease treatment
Soligenix is a late-stage biopharmaceutical company committed to developing and commercializing products to treat rare diseases where there is an unmet medical need.
<img alt="T-cell Image" class="initial loaded" data-cke-saved-src="https://www.soligenix.com/wp-content/uploads/2019/05/T-cells.png"; src="https://www.soligenix.com/wp-content/uploads/2019/05/T-cells.png"; style="animation:7s linear 0s 1 normal none running heroForegroundIn; border-style:none; box-sizing:inherit; color:inherit; display:block; font-family:object-fit: contain; height:549.438px; left:0px; max-width:100%; object-fit:contain; object-position:bottom right" ;="" opacity:1;="" position:relative;="" transform-origin:center="" center;="" transform:rotate(-45deg)="" translatex(0px);="" transition:opacity="" 0.5s="" ease="" 0s;="" visibility:visible;="" width:603.125px"="">
Scroll to next section

Specialized BioTherapeutics Pipeline

Soligenix has expertise in the development of orphan and unmet medical need indications including preclinical, manufacturing, regulatory and clinical expertise.

Preclinical Phase 1 Phase 2 Phase 3 Market
HyBryte™ for Cutaneous T-Cell Lymphoma (CTCL)
 
 
 
 
 
SGX942 for Oral Mucositis Treatment
 
 
 
 
 
SGX203 for Pediatric Crohn’s Disease
 
 
 
 
 
SGX201 for Radiation Enteritis Treatment
 
 
 
 
 

Orphan and/or Fast Track Designation

Denotes funding by NIH, BARDA, DTRA and/or FDA.

Public Health Solutions Pipeline

Soligenix has a number of Public Health programs, funded entirely by government grants and contracts, which focus on infectious disease and biodefense applications, including our most advanced vaccination program to prevent ricin poisoning.

Proof-of-Concept IND Phase 1 Phase 2/3 Market
RiVax® to Prevent Ricin Poisoning
 
 
 
 
 
SGX943 for Infectious Disease
 
 
 
 
 
ThermoVax®: Thermostabilized Vaccines for Global Use
 
 
 
 
 

Orphan and/or Fast Track Designation

Denotes funding by NIH, BARDA, DTRA and/or FDA.
Papers and chars with medical data

Corporate Presentation

May 10, 2021 Corporate Presentation
Papers and chars with medical data

Shareholder Update Letter

February 24, 2021 Shareholder Update Letter

The Latest

RESOURCES
EXTERNAL LINK

Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice 

COVID-19: Lai, C.Y., To, A., Wong, T.A.S., Lieberman, M.M., Clements, D.E., Senda, J.T., Ball, A.H., Pessaint, L., Andersen, H., Donini, O., Lehrer, A.T. Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice. 2021.

STAY ON TOP OF THE LATEST SOLIGENIX NEWS

SUBSCRIBE TO OUR NEWSLETTER
© Soligenix, 2021. All Rights Reserved.


 
Preclinical Phase 1 Phase 2 Phase 3 Market
HyBryte™ for Cutaneous T-Cell Lymphoma (CTCL) almost done [in phase 3]
 
 
 
 
 
SGX942 for Oral Mucositis Treatment   almost done [in phase 3]
 
 
 
 
 
SGX203 for Pediatric Crohn’s Disease   [phase 2 almost done]
 
 
 
 
 
SGX201 for Radiation Enteritis Treatment  [phase 1 going into phase 2]

ADDITION PIPELINE
 
Proof-of-Concept IND Phase 1 Phase 2/3 Market
RiVax® to Prevent Ricin Poisoning
 
 
 
 
 
SGX943 for Infectious Disease
 
 
 
 
 
ThermoVax®: Thermostabilized Vaccines for Global Use
 
 
 
 
 

Orphan and/or Fast Track Designation

Denotes funding by NIH, BARDA, DTRA and/or FDA.







 

PER  IHUB  MGMT 

02-07-2021
DISCLAIMER:  ONLY FOR MICK
https://investorshub.advfn.com/boards/profilea.aspx?user=1012
*The Board Monitor and herewithin , are not licensed brokers and assume NO responsibility for actions,
investments,decisions, or messages posted on this forum.
 
CONTENT ON THIS FORUM SHOULD NOT BE CONSIDERED ADVISORY NOR SOLICITATION 
AUTHORS MAY HAVE BUYS OR SELLS  WITH THE COMPANIES MENTIONED IN TRADING POSTERS SHOULD DUE DILIGENT BUYING OR SELLING.
ALL POSTING SHOULD BE CONSIDERED FOR INFORMATION ONLY. WE DO NOT RECOMMEND ANYONE BUY OR SELL ANY SECURITIES POSTED HEREWITHIN.

ANY trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.
Any


 








 
SNGX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#9399  Sticky Note SNGX: PR 1/4 and all recent progress for TruckingAngler 01/04/22 09:21:21 AM
#9458   $SNGX: Phase 2a Trial of SGX302 in Psoriasis budfoxfun 05/19/22 03:33:28 PM
#9457   AMTX > LOW ~ get in now 02opida 05/19/22 09:38:46 AM
#9456   SNGX > good one 02opida 05/19/22 09:38:16 AM
#9455   SNGX looking UP with avg $6 price target TruckingAngler 05/19/22 07:16:38 AM
#9454   The conference will be held May 23 through budfoxfun 05/18/22 03:17:03 PM
#9453   PRINCETON, N.J., May 18, 2022 /PRNewswire/ -- Soligenix, 02opida 05/18/22 08:07:24 AM
#9452   News: Soligenix to Present at the H.C. Wainwright jedijazz 05/18/22 07:42:21 AM
#9451   Patiently waiting for this party to get stated!!! BooDog 05/16/22 11:02:46 AM
#9450   Good comprehensive update from SNGX on all the ProfitScout 05/16/22 09:56:20 AM
#9449   SNGX p/r 5/13/2022: "Soligenix Announces Recent Accomplishments And TruckingAngler 05/13/22 08:13:14 AM
#9448   Saw my .405's filled and closed everything till BooDog 05/11/22 05:07:26 PM
#9447   SNGX after hours death spiral. WTH??? TruckingAngler 05/11/22 04:18:02 PM
#9446   I had an order in, they didn't fill BooDog 05/11/22 02:01:12 PM
#9445   SNGX 40 cents??!! WTH TruckingAngler 05/11/22 01:47:49 PM
#9444   My whole list is cracked. Some nice BooDog 05/11/22 12:12:52 PM
#9443   SNGX cup has CRACKed... TruckingAngler 05/11/22 10:56:07 AM
#9442   morning BooD 02opida 05/04/22 09:21:09 AM
#9441   only a 5oK day. Cup and handle BooDog 05/03/22 03:58:01 PM
#9440   HIGHS ARE GOOD SNGX 02opida 05/03/22 09:25:32 AM
#9439   52 week highs coming by July. Looking for $5 Tom turtles 05/02/22 04:24:51 PM
#9438   they will come here SNGX 02opida 04/27/22 11:07:21 AM
#9437   They get funding.....then it drops like a rock....wtf ? Tom turtles 04/26/22 01:56:43 PM
#9436   Thanks Boo I assume same, but that is TruckingAngler 04/26/22 09:12:50 AM
#9435   There's a lot of good going on for BooDog 04/26/22 08:42:42 AM
#9434   Wow. Now .51... I see no SNGX filings??? TruckingAngler 04/25/22 10:25:00 AM
#9433   WTH today 4/25 SNGX? TruckingAngler 04/25/22 09:46:27 AM
#9432   Crazy SNGX zero movement ? GLTA TruckingAngler 04/19/22 09:49:30 PM
#9431   Soligenix Receives $1.4M in Non-Dilutive Government Funding BooDog 04/19/22 07:45:08 AM
#9430   MORNING TA 02opida 04/09/22 08:51:04 AM
#9429   SNGX - Dr Schaber YouTube 4/8/2022: https://youtu.be/ehXOoJBihUA GLTA TruckingAngler 04/08/22 09:55:28 PM
#9428   morning TA & SNGX'ers 02opida 04/08/22 08:28:05 AM
#9427   SNGX with (1) 25,000 on the BID... TruckingAngler 04/07/22 12:05:46 PM
#9426   MOVING is right :) 02opida 04/01/22 08:37:21 AM
#9425   I don't see this staying under the $ BooDog 04/01/22 07:48:18 AM
#9424   SNGX high .70s again & Strong volume. Maybe TruckingAngler 03/31/22 02:40:10 PM
#9423   Soligenix COVID-19 Vaccine, CiVax(TM), Boosts Neutralizing Activity against 02opida 03/21/22 08:50:07 AM
#9422   Soligenix: 3/17/2022 - COVID-19 Vaccine, CiVax, Boosts Neutralizing TruckingAngler 03/17/22 11:01:37 AM
#9421   3/4/2022 “Deeper Dive into SNGX”: https://youtu.be/VlpZZI3muPY TruckingAngler 03/08/22 07:11:39 AM
#9420   Yah...no shit..... SOMETHING ! Tom turtles 02/02/22 10:04:30 AM
#9419   Just get back over the $. BooDog 01/27/22 10:57:46 AM
#9418   POS Tom turtles 01/11/22 09:58:11 AM
#9417   This cow is dead Tom turtles 01/11/22 09:45:41 AM
#9416   All time low...lovely Tom turtles 01/10/22 09:37:55 AM
#9415   this cow will fly soon imho upanddown66 01/10/22 08:18:10 AM
#9414   Lol indeed my friend. I recall them saying Cosa 01/07/22 03:44:57 PM
#9413   ASStute investor obviously.. TruckingAngler 01/07/22 10:00:59 AM
#9412   Time for what ? Another offering ? Tom turtles 01/07/22 04:45:34 AM
#9411   SNGX is time... TruckingAngler 01/06/22 04:23:46 PM
#9410   It's time. Cosa 01/06/22 03:52:13 PM
#9409   Thanks again for your in depth ANALysis & TruckingAngler 01/05/22 03:52:16 PM
PostSubject
Consent Preferences